Alterations in penicillin-binding protein 1A confer resistance to β-lactam antibiotics in Helicobacter pylori
Antimicrobial Agents and Chemotherapy , Volume 46 - Issue 7 p. 2229- 2233
Most Helicobacter pylori strains are susceptible to amoxicillin, an important component of combination therapies for H. pylori eradication. The isolation and initial characterization of the first reported stable amoxicillin-resistant clinical H. pylori isolate (the Hardenberg strain) have been published previously, but the underlying resistance mechanism was not described. Here we present evidence that the β-lactam resistance of the Hardenberg strain results from a single amino acid substitution in HP0597, a penicillin-binding protein 1A (PBP1A) homolog of Escherichia coli. Replacement of the wild-type HP0597 (pbp1A) gene of the amoxicillin-sensitive (Amxs) H. pylori strain 1061 by the Hardenberg pbp1A gene resulted in a 100-fold increase in the MIC of amoxicillin. Sequence analysis of pbp1A of the Hardenberg strain, the Amxs H. pylori strain 1061, and four amoxicillin-resistant (Amxr) 1061 transformants revealed a few amino acid substitutions, of which only a single Ser414→Arg substitution was involved in amoxicillin resistance. Although we cannot exclude that mutations in other genes are required for high-level amoxicillin resistance of the Hardenberg strain, this amino acid substitution in PBP1A resulted in an increased MIC of amoxicillin that was almost identical to that for the original Hardenberg strain.
|Antimicrobial Agents and Chemotherapy
|Department of Gastroenterology & Hepatology
Gerrits, M., Schuijffel, D., van Zwet, A., Kuipers, E., Vandenbroucke-Grauls, C., & Kusters, J. (2002). Alterations in penicillin-binding protein 1A confer resistance to β-lactam antibiotics in Helicobacter pylori. Antimicrobial Agents and Chemotherapy, 46(7), 2229–2233. doi:10.1128/AAC.46.7.2229-2233.2002